[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.204.193.85. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
1.
Noble  GR Epidemiological and clinical aspects of influenza. Beare  ASed. Basic and Applied Influenza Research. Boca Raton, Fla CRC Press1982;11- 50Google Scholar
2.
Nguyen-Van Tam  JS Epidemiology of influenza. Nicholson  KGWebster  RGHay  AJeds. Textbook of Influenza. Oxford, England Blackwell Science1998;181- 206Google Scholar
3.
Serfling  RE Methods for current statistical analysis of excess pneumonia-influenza deaths.  Public Health Rep 1963;78494- 506Google ScholarCrossref
4.
Lui  KJKendal  AP Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985.  Am J Public Health 1987;77712- 716PubMedGoogle ScholarCrossref
5.
Simonsen  LClarke  MJWilliamson  GDStroup  DFArden  NHSchonberger  LB The impact of influenza epidemics on mortality: introducing a severity index.  Am J Public Health 1997;871944- 1950PubMedGoogle ScholarCrossref
6.
Simonsen  LSchonberger  LBStroup  DFArden  NHCox  NJ The impact of influenza on mortality in the US. Brown  LEHampson  AWWebster  RGeds. Options for the Control of Influenza III. New York, NY Elsevier Science1996;26- 33Google Scholar
7.
Thompson  WWShay  DKWeintraub  E  et al.  Mortality associated with influenza and respiratory syncytial virus in the United States.  JAMA 2003;289179- 186PubMedGoogle ScholarCrossref
8.
Simonsen  LReichert  TABlackwelder  WCMiller  MA Benefits of influenza vaccination on influenza-related mortality among elderly in the US: an unexpected finding. Kawaoka  Yed. Options for the Control of Influenza V. New York, NY Elsevier Science2004;163- 167Google Scholar
9.
Bridges  CBHarper  SAFukuda  KUyeki  TMCox  NJSingleton  JAAdvisory Committee on Immunization Practices, Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).  MMWR Recomm Rep 2003;521- 34PubMedGoogle Scholar
10.
National Center for Health Statistics, The National Immunization Survey.  Hyattsville, Md National Center for Health Statistics2002;
11.
Keepel  KGPearcy  JN Healthy People 2000: An Assessment Based on the Health Status Indicators for the United States and Each State.  Hyattsville, Md National Center for Health Statistics2000;1- 31
12.
Centers for Disease Control, Consultation on the National Impact of Influenza and Method for Rapid Assessment of the Effectiveness of Influenza Vaccination.  Atlanta, Ga Global Health Action1997;
13.
Fedson  DSWajda  ANicol  JPHammond  GWKaiser  DLRoos  LL Clinical effectiveness of influenza vaccination in Manitoba, 1982-83 and 1985-86.  JAMA 1993;2701956- 1961PubMedGoogle ScholarCrossref
14.
Nichol  KLWuorenma  Jvon Sternberg  T Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens.  Arch Intern Med 1998;1581769- 1776PubMedGoogle ScholarCrossref
15.
Nichol  KL Efficacy/clinical effectiveness of inactivated influenza virus vaccines in adults. Nicholson  KWebster  RGHay  Aeds. Textbook of Influenza. Oxford, England Blackwell Science1998;358- 372Google Scholar
16.
Nordin  JMullooly  JPoblete  S  et al.  Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York and Oregon: data from 3 health plans.  J Infect Dis 2001;184665- 670PubMedGoogle ScholarCrossref
17.
Nichol  KLNordin  JMullooly  JLask  RFillbrandt  KIwane  M Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly.  N Engl J Med 2003;3481322- 1332PubMedGoogle ScholarCrossref
18.
Nichol  KL The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines.  Vaccine 2003;211769- 1775PubMedGoogle ScholarCrossref
19.
Vu  TFarish  SJenkins  MKelly  H A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community.  Vaccine 2002;201831- 1836PubMedGoogle ScholarCrossref
20.
US Bureau of Census, Historical National Population Estimates.  Washington, DC US Census Bureau2000;
21.
National Center for Health Statistics, Vital Statistics Mortality Data: Multiple Cause Detail, 1969-1995.  Hyattsville, Md National Center for Health Statistics1993;
22.
National Center for Health Statistics, Instructions for Classifying the Underlying Cause of Death.  Hyattsville, Md National Center for Health Statistics1992;
23.
National Center for Health Statistics, International Classification of Diseases, 10th Revision (ICD-10).  Hyattsville, Md National Center for Health Statistics2002;
24.
Miller  MA Considerations for adding pneumonia and influenza vaccines to public health programmes.  Vaccine 1999;17 ((suppl 1)) S95- S98PubMedGoogle ScholarCrossref
25.
Centers for Disease Control and Prevention, Racial/ethnic disparities in influenza and pneumococcal vaccination levels among persons aged ≥65 years—United States, 1989-2001.  MMWR Morb Mortal Wkly Rep 2003;52958- 962PubMedGoogle Scholar
26.
Brammer  TLMurray  ELFukuda  KHall  HEKlimov  ACox  NJ Surveillance of influenza—United States, 1997-98, 1998-99, and 1999-00 seasons.  MMWR Surveill Summ 2002;511- 10PubMedGoogle Scholar
27.
Govaert  TMThijs  CTMasurel  NSprenger  MJDinant  GJKnottnerus  JA The efficacy of influenza vaccination in elderly individuals.  JAMA 1994;2721661- 1665PubMedGoogle ScholarCrossref
28.
Reichert  TASimonsen  LSharma  APardo  SAFedson  DSMiller  MA Influenza and the winter increase in mortality in the United States, 1959-99.  Am J Epidemiol 2004;160492- 502PubMedGoogle ScholarCrossref
29.
Centers for Disease Control and Prevention, Update: influenza activity—United States and worldwide, 1997-98 season, and composition of the 1998-99 influenza vaccine.  MMWR Morb Mortal Wkly Rep 1998;47280- 284PubMedGoogle Scholar
30.
Bridges  CBThompson  WWMeltzer  MI  et al.  Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial.  JAMA 2000;2841655- 1663PubMedGoogle ScholarCrossref
31.
Simonsen  LReichert  TAMiller  MA The virtues of antigenic sin: consequences of pandemic recycling on influenza-associated mortality. Kawaoka  Yed. Options for the Control of Influenza V. New York, NY Elsevier Science2004;791- 794Google Scholar
32.
Goronzy  JJFulbright  JWCrowson  CSPoland  GAO’Fallon  WMWeyand  CM Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals.  J Virol 2001;7512182- 12187PubMedGoogle ScholarCrossref
33.
Fedson  DSWajda  ANicol  JPRoos  LL Disparity between influenza vaccination rates and risks for influenza-associated hospital discharge and death in Manitoba in 1982-1983.  Ann Intern Med 1992;116550- 555PubMedGoogle ScholarCrossref
34.
Bratzler  DWHouck  PMJiang  H  et al.  Failure to vaccinate Medicare inpatients: a missed opportunity.  Arch Intern Med 2002;1622349- 2356PubMedGoogle ScholarCrossref
35.
Mangtani  PCumberland  PHodgson  CRRoberts  JACutts  FTHall  AJ A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database.  J Infect Dis 2004;1901- 10PubMedGoogle ScholarCrossref
36.
Voordouw  ACSturkenboom  MCDieleman  JP  et al.  Annual revaccination against influenza and mortality risk in community-dwelling elderly persons.  JAMA 2004;2922089- 2095PubMedGoogle ScholarCrossref
37.
Maier  T Thousands more deaths: CDC begins a study to examine how many more may die without flu shots as experts say toll may be substantial.  New York Newsday. November3 2004;Google Scholar
38.
Kang  IHong  MSNolasco  H  et al.  Age-associated change in the frequency of memory CD4+ T cells impairs long term CD4+ T cell responses to influenza vaccine.  J Immunol 2004;173673- 681PubMedGoogle ScholarCrossref
Original Investigation
February 14, 2005

Impact of Influenza Vaccination on Seasonal Mortality in the US Elderly Population

Author Affiliations

Author Affiliations: National Institute of Allergy and Infectious Diseases (NIAID) (Dr Simonsen) and Fogarty International Center (Drs Viboud and Miller), National Institutes of Health, Bethesda, Md; and Entropy Research Institute, Boston, Mass (Dr Reichert).

Arch Intern Med. 2005;165(3):265-272. doi:10.1001/archinte.165.3.265
Abstract

Background  Observational studies report that influenza vaccination reduces winter mortality risk from any cause by 50% among the elderly. Influenza vaccination coverage among elderly persons (≥65 years) in the United States increased from between 15% and 20% before 1980 to 65% in 2001. Unexpectedly, estimates of influenza-related mortality in this age group also increased during this period. We tried to reconcile these conflicting findings by adjusting excess mortality estimates for aging and increased circulation of influenza A(H3N2) viruses.

Methods  We used a cyclical regression model to generate seasonal estimates of national influenza-related mortality (excess mortality) among the elderly in both pneumonia and influenza and all-cause deaths for the 33 seasons from 1968 to 2001. We stratified the data by 5-year age group and separated seasons dominated by A(H3N2) viruses from other seasons.

Results  For people aged 65 to 74 years, excess mortality rates in A(H3N2)-dominated seasons fell between 1968 and the early 1980s but remained approximately constant thereafter. For persons 85 years or older, the mortality rate remained flat throughout. Excess mortality in A(H1N1) and B seasons did not change. All-cause excess mortality for persons 65 years or older never exceeded 10% of all winter deaths.

Conclusions  We attribute the decline in influenza-related mortality among people aged 65 to 74 years in the decade after the 1968 pandemic to the acquisition of immunity to the emerging A(H3N2) virus. We could not correlate increasing vaccination coverage after 1980 with declining mortality rates in any age group. Because fewer than 10% of all winter deaths were attributable to influenza in any season, we conclude that observational studies substantially overestimate vaccination benefit.

×